Previous 10 | Next 10 |
2024-02-26 09:45:00 ET Particular financial metrics have been proven to indicate market-beating potential when analyzing stocks. Three examples are businesses with consistently growing dividend payments and a low payout ratio, steady share repurchases, and a high and rising return on invest...
Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Securities 2024 Animal Health Summit on Thursday, February 29, 2024. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts. He is scheduled to present...
2024-02-19 19:34:01 ET Summary Beating the S&P 500 is difficult due to skewed market returns favoring a few high-performing stocks. 5 dividend growth stocks that have excellent track records, outperforming the S&P 500 over 5-year rolling periods are highlighted. Zoetis...
2024-02-14 06:02:07 ET Zoetis Inc. (ZTS) Q4 2023 Earnings Conference Call February 13, 2024, 8:30 a.m. ET Company Participants Kristin Peck - CEO Wetteny Joseph - CFO Steve Frank - VP of IR Conference Call Participants Erin Wright - Morgan Stanley ...
2024-02-13 15:30:16 ET Image source: The Motley Fool. Zoetis (NYSE: ZTS) Q4 2023 Earnings Call Feb 13, 2024 , 8:30 a.m. ET Operator Continue reading For further details see: Zoetis (ZTS) Q4 2023 Earnings Call Transcript
2024-02-13 12:11:51 ET More on Zoetis Zoetis Inc. 2023 Q4 - Results - Earnings Call Presentation Animal Kingdom's Ally: Zoetis And Its Path To 10%+ Returns Zoetis Non-GAAP EPS of $1.24 misses by $0.08, revenue of $2.2B beats by $10M Zoetis Q4 2023 Earnings Pr...
2024-02-13 07:02:37 ET More on Zoetis Animal Kingdom's Ally: Zoetis And Its Path To 10%+ Returns Zoetis Q4 2023 Earnings Preview Seeking Alpha’s Quant Rating on Zoetis Historical earnings data for Zoetis Dividend scorecard for Zoetis ...
For Fourth Quarter 2023, Zoetis Reports Revenue of $2.2 Billion, Growing 8%, and Net Income of $525 Million, or $1.14 per Diluted Share, Increasing 14% and 15%, Respectively, on a Reported Basis Delivers 8% Operational Growth in Revenue and 6% Operational Growth in Adjusted Net Income for...
ESSA Pharma Inc. (EPIX) is expected to report $-0.17 for Q1 2024 QuidelOrtho Corp Com (QDEL) is expected to report $2.01 for Q4 2023 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 Portsmouth Square, Inc. (PRSI) is expected to report for Q2 2024 Similarweb Ltd. (SMWB) ...
2024-02-12 11:03:36 ET More on Zoetis Animal Kingdom's Ally: Zoetis And Its Path To 10%+ Returns Seeking Alpha’s Quant Rating on Zoetis Historical earnings data for Zoetis Dividend scorecard for Zoetis Financial information for Zoetis ...
News, Short Squeeze, Breakout and More Instantly...
Zoetis Inc. Class A Company Name:
ZTS Stock Symbol:
NYSE Market:
2024-05-30 08:15:00 ET Since its spinoff from Pfizer in 2013, animal healthcare behemoth Zoetis (NYSE: ZTS) has seen its cash from operations nearly quintuple as a stand-alone company. Powered by a diverse array of animal health offerings that serve both the companion an...
SAN FRANCISCO, May 29, 2024 (GLOBE NEWSWIRE) -- Hagens Berman is urging investors who suffered substantial losses in Zoetis Inc. (NYSE: ZTS) to promptly report their losses here . Additionally, individuals with relevant knowledge who may assist in the investigation are encouraged to conta...
The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.432 per share for the third quarter of 2024. The dividend will be paid on Wednesday, September 4, 2024, to all holders of record of the Company’s common stock as of the close of business on Thursday, July 18...